Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Environmental and Molecular Mutagenesis

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/em.20369PMID 18213650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans

  2008cited by this paper
• IPCS framework for analysing the relevance of a cancer mode of action for humans

  2006influential reference
• Concise International Chemical Assessment Document 68

  2006cited by this paper
• A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data.

  2005cited by this paper
• Case study: weight of evidence evaluation of the human health relevance of thiamethoxam-related mouse liver tumors.

  2005cited by this paper
• DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard

  2005cited by this paper
• Thiamethoxam induced mouse liver tumors and their relevance to humans. Part 2: species differences in response.

  2005cited by this paper
• Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data

  2005cited by this paper
• Harmonization Project Document No . 2 CHEMICAL-SPECIFIC ADJUSTMENT FACTORS FOR INTERSPECIES DIFFERENCES AND HUMAN VARIABILITY : GUIDANCE DOCUMENT FOR USE OF DATA IN DOSE / CONCENTRATION – RESPONSE ASSESSMENT

  2005cited by this paper
• Inhaled Formaldehyde: Exposure Estimation, Hazard Characterization, and Exposure-Response Analysis

  2003cited by this paper
• A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action

  2003cited by this paper
• Technical Guidance Document on risk Assessment. Part 1. Part 2

  2002cited by this paper
• Revisiting the rodent repairadox

  2001cited by this paper
• IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis.

  2001cited by this paper
• Hazard and Dose-Response Assessment and Characterization

  2000cited by this paper
• There is substantial agreement among interspecies estimates of DNA repair activity.

  1996cited by this paper
• The Environment and Disease: Association or Causation?

  1965cited by this paper

• A Pragmatic Workflow for Human Relevance Assessment of Toxicological Pathways and Associated New Approach Methodologies.

  2025cites this paper
• Adversity Considerations for Thyroid Follicular Cell Hypertrophy and Hyperplasia in Nonclinical Toxicity Studies: Results From the 6th ESTP International Expert Workshop

  2020cites this paper
• Weight of Evidence for Hazard Identification: A Critical Review of the Literature

  2018cites this paper
• The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions

  2017influential citation
• Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity.

  2017cites this paper
• AOPs in hazard characterization for human health

  2017cites this paper
• Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision Making

  2016cites this paper
• Carcinogenicity and mode of action evaluation for alpha-hexachlorocyclohexane: Implications for human health risk assessment.

  2016cites this paper
• The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor.

  2015cites this paper
• Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.

  2015cites this paper
• Neurotoxicity may be an overlooked consequence of benzo[a]pyrene exposure that is relevant to human health risk assessment.

  2015cites this paper
• Integrating toxicogenomics into human health risk assessment: Lessons learned from the benzo[a]pyrene case study

  2015cites this paper
• Mode of action and human relevance of pronamide-induced rat thyroid tumors.

  2015cites this paper
• Mode of Action/Human Relevance Framework

  2015cites this paper
• Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.

  2015influential citation
• Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study

  2014cites this paper
• Application of benchmark dose modeling to protein expression data in the development and analysis of mode of action/adverse outcome pathways for testicular toxicity

  2014cites this paper
• Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study

  2014cites this paper
• Experimental Study of Islanding‐Prevention Method by Harmonic Injection Synchronized with Exciting Current Harmonics of Pole Transformer

  2014cites this paper
• Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence

  2014cites this paper
• DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry.

  2014cites this paper
• The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events

  2014cites this paper
• Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment.

  2013cites this paper
• New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis

  2013cites this paper
• Advancing human health risk assessment: Integrating recent advisory committee recommendations

  2013cites this paper
• Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance.

  2012cites this paper
• Preliminary evaluation of the human relevance of respiratory tumors observed in rodents exposed to naphthalene.

  2012cites this paper
• Reverse engineering adverse outcome pathways

  2011cites this paper
• Risk Assessment Approaches for Carcinogenic Food Contaminants

  2011cites this paper
• Démarches d'évaluation des risques relatifs aux contaminants alimentaires cancérogènes

  2011cites this paper
• Follow‐up actions from positive results of in vitro genetic toxicity testing

  2011cites this paper
• Strategies in case of positive in vivo results in genotoxicity testing.

  2011cites this paper
• Derived Reference Doses (RfDs) for the environmental degradates of the herbicides alachlor and acetochlor: results of an independent expert panel deliberation.

  2010cites this paper
• Toxicity Testing in the 21st Century: How will it Affect Risk Assessment?

  2010cites this paper
• The vision of toxicity testing in the 21st century: moving from discussion to action.

  2010cites this paper
• Risk Assessment Practice for Essential Metals

  2010cites this paper
• Biomarkers for Environmental Exposure

  2010cites this paper
• Health ranking of ingested semi-volatile organic compounds in house dust: an application to France.

  2010cites this paper
• Mode of Action Analysis and Human Relevance of Liver Tumors Induced by PPARα Activation

  2010cites this paper
• Experimental Animal Studies and Carcinogenicity

  2010cites this paper
• Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment.

  2010cites this paper
• Letter to the editor in response to Forristal et al.: Improving the quality of risk assessments in Canada using a principle-based approach, regulatory toxicology and pharmacology 50 (2008) 336-344.

  2009cites this paper
• The use of Mechanisms and Modes of Toxic Action in Integrated Testing Strategies: The Report and Recommendations of a Workshop held as part of the European Union OSIRIS Integrated Project

  2009cites this paper
• Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.

  2009cites this paper
• Pragmatic Challenges for the Vision of Toxicity Testing in the 21st Century in a Regulatory Context: Another Ames Test? …or a New Edition of “the Red Book”?

  2009cites this paper
• REPORT ON CARCINOGENS; AVAILABILITY OF THE DRAFT BACKGROUND DOCUMENT FOR STYRENE; REQUEST FOR COMMENTS ON THE DRAFT BACKGROUND DOCUMENT FOR STYRENE; ANNOUNCEMENT OF THE STYRENE EXPERT PANEL MEETING

  2008cites this paper
• FORUM Systems Biology and Mode of Action Based Risk Assessment

  2008cites this paper
• In vivo Approaches to Study Mechanism of Action of Genotoxic Carcinogens

  2008cites this paper
• Systems biology and mode of action based risk assessment.

  2008cites this paper